FOLD Amicus Therapeutics Inc

Amicus Therapeutics Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of next-generation medicines.

$10.70  -0.09 (-0.83%)
As of 11/30/2021 15:59:58 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/31/2007
Outstanding shares:  278,638,872
Average volume:  2,220,106
Market cap:   $3,009,299,818
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    03152W109
ISIN:        US03152W1099
Sedol:      B19FQ48
Valuation   (See tab for details)
PE ratio:   -12.60
PB ratio:   7.98
PS ratio:   10.24
Return on equity:   -63.35%
Net income %:   -81.17%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy